Indonesia’s healthcare spending reached Rp664 trillion in 2025, roughly double the amount recorded a decade earlier. The increase highlights the growing scale of the country’s healthcare system, while raising questions about how the money is funded, distributed, and used.
The government sees this expansion as an opportunity to strengthen the domestic healthcare industry. However, data from Indonesia’s National Health Accounts and the World Health Organization (WHO) also point to persistent challenges, including household healthcare costs, hospital-focused treatment, and the need for more efficient spending.
Indonesia’s Healthcare Spending Has Nearly Doubled in a Decade
Indonesia’s national healthcare expenditure reached Rp664 trillion in 2025, according to figures reported by Bisnis.com on October 5, 2026. The increase reflects a broader expansion in healthcare spending over the past decade.
Earlier data from the Ministry of Health’s National Health Accounts 2023 show that total healthcare expenditure stood at Rp614.5 trillion in 2023, compared with Rp324.6 trillion in 2014. The 2023 figure represents an increase of approximately 89% over that period.
The WHO’s Health Accounts Indonesia 2024: Strengthening the Evidence for Sustainable Health Financing, published on February 12, 2026, reported healthcare expenditure of Rp639.9 trillion in 2024, equivalent to 2.9% of gross domestic product (GDP). The report also put annual healthcare spending at approximately Rp2.3 million per capita.
These figures show the scale of Indonesia’s expanding healthcare expenditure across the three reporting years. The totals come from different annual datasets and should be read in the context of their respective reporting periods.
The Ministry of Health sees this growth as more than an increase in healthcare costs. Lucia Rizka Andalusia said greater expenditure could support the national economy, particularly if Indonesia strengthens domestic manufacturing of medical devices and increases local production rather than relying primarily on distribution.
The strategy could create wider economic benefits by supporting domestic industry. The government has also highlighted the development of hospitals in regional areas, particularly private hospitals, as part of the expansion of healthcare services.
Public Funding Covers Most Healthcare Costs, but Households Still Pay
Public financing has become an increasingly important part of Indonesia’s healthcare system. According to the National Health Accounts 2023, public healthcare expenditure reached Rp352.5 trillion, or 57.4% of total spending, in 2023.
The breakdown included Rp166.4 trillion from social health insurance schemes, including the National Health Insurance programme, known as Jaminan Kesehatan Nasional (JKN), and work accident insurance. Local governments contributed Rp145.4 trillion, while central government spending reached Rp40.7 trillion.
The balance of healthcare expenditure came from non-public sources and direct household payments. Private healthcare expenditure, excluding household out-of-pocket payments, reached Rp86.5 trillion, representing 14.1% of total spending.
Meanwhile, households paid Rp175.5 trillion out of pocket in 2023, equivalent to 28.6% of national healthcare expenditure. Although the share has declined from 43.7% in 2014, direct payments remain a substantial component of healthcare financing.
The WHO reported a similar pattern in 2024. Public financing accounted for 58.5% of healthcare expenditure, while household out-of-pocket payments represented 28.3%.
The continued role of household payments matters because the expansion of public financing does not automatically eliminate direct healthcare costs. The National Health Accounts report also indicates that out-of-pocket spending is unevenly distributed across income groups. In 2023, the wealthiest household quintile accounted for Rp98.3 trillion, or approximately 56% of total out-of-pocket spending, compared with Rp14.9 trillion, or 8.5%, for the poorest quintile.
The report identifies gaps related to JKN enrolment status as one factor behind continued out-of-pocket payments among lower-income groups. Expanding effective coverage and improving access to services therefore remain important parts of strengthening financial protection.
Hospitals and Medicines Account for Significant Spending
Where healthcare money is spent is another key part of the picture. The National Health Accounts 2023 recorded Rp313.9 trillion in spending through hospitals, equal to 51.1% of total healthcare expenditure that year.
JKN spending was also concentrated at referral-level healthcare facilities, known as Fasilitas Kesehatan Rujukan Tingkat Lanjutan (FKRTL). In 2023, JKN expenditure reached Rp164.6 trillion, of which Rp138.7 trillion, or 84.3%, went to referral-level facilities.
The report found that a large share of JKN spending supported inpatient curative care. It recommends strengthening primary healthcare facilities, known as Fasilitas Kesehatan Tingkat Pertama (FKTP), and increasing preventive and health-promotion activities to help reduce the burden of treatment at hospitals.
Primary care is particularly relevant to how healthcare resources are allocated. Earlier intervention and stronger preventive services can form part of a more balanced system, rather than placing most of the pressure on hospitals after patients become ill.
Pharmaceuticals represent another substantial spending category. Indonesia’s pharmaceutical expenditure reached Rp126.7 trillion in 2023, accounting for 20.6% of total healthcare spending, according to the figures cited in the National Health Accounts material.
Of that amount, Rp8.6 trillion was spent through pharmaceutical purchasing using the government’s e-catalogue system, equivalent to 6.8% of pharmaceutical expenditure. The figures highlight the scale of medicine-related spending and the importance of examining how pharmaceutical products are purchased.
The National Health Accounts also shows that household out-of-pocket spending is used for different types of healthcare services, including medicines, hospital treatment, outpatient care, and preventive services. In 2023, medicines accounted for Rp53.7 trillion of household out-of-pocket expenditure, or approximately 30.6% of the total.
Together, the figures show that healthcare spending is spread across public insurance, government budgets, hospitals, pharmaceuticals, and direct payments by households. Understanding these different channels is essential to assessing how healthcare resources are being used.
Indonesia Faces Growing Pressure to Improve Healthcare Efficiency
The increase in healthcare expenditure has strengthened the role of public financing, but it has also increased the importance of sustainable funding and efficient resource allocation.
The WHO’s 2024 health accounts report identifies sustainable public financing, stronger primary care, and better cost control as important priorities. The report also emphasizes the need for more detailed expenditure data to support decisions about how healthcare resources should be allocated.
Indonesia’s National Health Accounts uses the WHO’s System of Health Accounts 2011 framework to classify healthcare expenditure. The government released the health accounts data on December 17, 2025, providing a basis for tracking spending by financing source, healthcare provider, and service function.
The WHO has also planned support for Indonesia during 2026–2027 to strengthen the institutional use of health accounts. The work includes improving the use of expenditure data, developing more detailed accounts for pharmaceutical spending and specific diseases, and supporting interoperability between data systems.
These priorities are relevant as Indonesia continues to expand healthcare coverage and increase spending through JKN and government budgets. The National Health Accounts report records a 34.3% increase in social health insurance expenditure in 2023, reaching Rp166.4 trillion, alongside an increase in service visits.
The same report points to the importance of monitoring spending against service outputs and outcomes, improving local government financial management, expanding active JKN membership, and strengthening primary care. These measures are intended to help ensure that higher expenditure translates into effective services while reducing unnecessary pressure on the healthcare system.
This article draws on two original articles and the National Health Accounts Indonesia reports for 2021 and 2023. The original articles can be accessed through the links below:
- Bisnis.com — Indonesia’s Healthcare Spending Reaches Rp664 Trillion in 2025, Nearly Doubling in a Decade
- World Health Organization (WHO) — Indonesia Health Accounts 2024: Strengthening Evidence for Sustainable Health Financing
Additional data and expenditure breakdowns are drawn from Indonesia’s National Health Accounts reports for 2021 and 2023.
This article was created with AI assistance.
We make every effort to ensure the accuracy of our content, some information may be incorrect or outdated. Please let us know of any corrections at [email protected].
Read More

Saturday, 21-11-26
